Centene vs. CMS: Legal Clash Over Medicare Star Ratings
Centene challenges CMS's 2027 star ratings in lawsuit, exposing tensions in the insurance industry and implications for Medicare Advantage strategies.
Centene challenges CMS's 2027 star ratings in lawsuit, exposing tensions in the insurance industry and implications for Medicare Advantage strategies.
Humana's stock rises 15% as Medicare Advantage star ratings improve dramatically, setting the stage for a competitive market shift in healthcare insurance.
CMS updates Medicare Advantage Star Ratings significantly impact Humana and Alignment Healthcare's future performance, affecting federal payments and market positioning.
CMS announces new star rating thresholds for Medicare Advantage plans, impacting insurer bonuses and challenging standards for healthcare quality and performance.
Elevance sues CMS over Medicare Advantage star ratings, claiming $115 million loss in bonuses and inconsistencies in evaluation methods among insurers.
Morgan Stanley downgrades Humana amid Medicare Advantage concerns highlighting risks to its profitability and financial forecast. Understand the implications for insurers.
CMS's 2027 Proposed Rule for Medicare Advantage revises Star Ratings by focusing on clinical quality and member experience, delaying equity-focused rewards, and enhancing integrated care for dual-eligible populations.
Explore the CMS CY 2027 Proposed Rule's impact on Medicare Advantage quality measures, Star Ratings, and integration of dual-eligible members with Medicaid. Key insights for health plans and state agencies.
CMS releases 2027 Medicare Advantage and Part D proposed rule focusing on Star Ratings adjustments, regulatory burden reduction, and program spending projections.
CMS released 2027 proposed Medicare Advantage rules focusing on simplifying Star Ratings, expanding risk adjustment data use, and streamlining reporting requirements.